150 related articles for article (PubMed ID: 8461542)
1. Prevention of corticosteroid bone loss.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
Osteoporos Int; 1993; 3 Suppl 1():141-3. PubMed ID: 8461542
[TBL] [Abstract][Full Text] [Related]
2. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica.
Healey JH; Paget SA; Williams-Russo P; Szatrowski TP; Schneider R; Spiera H; Mitnick H; Ales K; Schwartzberg P
Calcif Tissue Int; 1996 Feb; 58(2):73-80. PubMed ID: 8998681
[TBL] [Abstract][Full Text] [Related]
4. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate.
Bianda T; Linka A; Junga G; Brunner H; Steinert H; Kiowski W; Schmid C
Calcif Tissue Int; 2000 Aug; 67(2):116-21. PubMed ID: 10920215
[TBL] [Abstract][Full Text] [Related]
5. Effect of calcitriol on bone loss after cardiac or lung transplantation.
Sambrook P; Henderson NK; Keogh A; MacDonald P; Glanville A; Spratt P; Bergin P; Ebeling P; Eisman J
J Bone Miner Res; 2000 Sep; 15(9):1818-24. PubMed ID: 10977001
[TBL] [Abstract][Full Text] [Related]
6. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
7. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.
Gallagher JC; Fowler SE; Detter JR; Sherman SS
J Clin Endocrinol Metab; 2001 Aug; 86(8):3618-28. PubMed ID: 11502787
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.
Richy F; Ethgen O; Bruyere O; Reginster JY
Osteoporos Int; 2004 Apr; 15(4):301-10. PubMed ID: 14740153
[TBL] [Abstract][Full Text] [Related]
9. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
Flicker L; Hopper JL; Larkins RG; Lichtenstein M; Buirski G; Wark JD
Osteoporos Int; 1997; 7(1):29-35. PubMed ID: 9102059
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
11. Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study.
Luengo M; Pons F; Martinez de Osaba MJ; Picado C
Thorax; 1994 Nov; 49(11):1099-102. PubMed ID: 7831624
[TBL] [Abstract][Full Text] [Related]
12. Calcium and vitamin D therapy in corticosteroid bone loss: what is the evidence.
Sambrook PN
J Rheumatol; 1996 Jun; 23(6):963-4. PubMed ID: 8782123
[No Abstract] [Full Text] [Related]
13. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
[TBL] [Abstract][Full Text] [Related]
14. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.
Adachi JD; Bensen WG; Bell MJ; Bianchi FA; Cividino AA; Craig GL; Sturtridge WC; Sebaldt RJ; Steele M; Gordon M; Themeles E; Tugwell P; Roberts R; Gent M
Br J Rheumatol; 1997 Feb; 36(2):255-9. PubMed ID: 9133941
[TBL] [Abstract][Full Text] [Related]
15. Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial.
McDonald CF; Zebaze RM; Seeman E
Osteoporos Int; 2006 Oct; 17(10):1546-51. PubMed ID: 16832714
[TBL] [Abstract][Full Text] [Related]
16. Effect of long-term calcitonin administration on steroid-induced osteoporosis after cardiac transplantation.
Kapetanakis EI; Antonopoulos AS; Antoniou TA; Theodoraki KA; Zarkalis DA; Sfirakis PD; Chilidou DA; Alivizatos PA
J Heart Lung Transplant; 2005 May; 24(5):526-32. PubMed ID: 15896748
[TBL] [Abstract][Full Text] [Related]
17. Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
Gürlek A; Bayraktar M; Gedik O
Calcif Tissue Int; 1997 Jul; 61(1):39-43. PubMed ID: 9192511
[TBL] [Abstract][Full Text] [Related]
18. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin therapy in osteoporosis.
Muñoz-Torres M; Alonso G; Raya MP
Treat Endocrinol; 2004; 3(2):117-32. PubMed ID: 15743107
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
Välimäki MJ; Kinnunen K; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Nieminen M
Osteoporos Int; 1999; 10(2):128-36. PubMed ID: 10501793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
